InterCure Ltd. Form 6-K Summary
Business Context and Reporting Period
InterCure Ltd., an Israeli company and foreign private issuer, furnished this Form 6-K for December 2023. The filing reports actions taken at the Company’s Annual General Meeting of Shareholders held on December 14, 2023.
Shareholder Meeting Results
Shareholders approved all five proposals presented at the meeting, with the required majority for each proposal. The proposals were described in the Company’s November 8, 2023 Notice and Proxy Statement, previously furnished as Exhibit 99.1 to a Form 6-K.
Financial Metrics and Material Changes
This filing does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other operating or financial metrics. It does not report a material financial change versus a prior comparable period.
Outlook, Risks, and Unusual Items
The filing contains no management outlook, risk updates, contingencies, or unusual financial items. The primary disclosure is the approval of the five shareholder proposals.
Investor Verification Points
- Review the November 8, 2023 Notice and Proxy Statement to identify the five proposals approved.
- Verify the voting requirements and detailed resolutions in the Company’s meeting materials.
- Consult subsequent filings for any implementation details or effects arising from the approved proposals.